BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38108152)

  • 1. Exopolysaccharide β-(2,6)-levan-type fructans have a molecular-weight-dependent modulatory effect on Toll-like receptor signalling.
    Akkerman R; Oerlemans MMP; Ferrari M; Fernández-Lainez C; de Haan BJ; Faas MM; Walvoort MTC; de Vos P
    Food Funct; 2024 Jan; 15(2):676-688. PubMed ID: 38108152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β(2→6)-Type fructans attenuate proinflammatory responses in a structure dependent fashion via Toll-like receptors.
    Fernández-Lainez C; Akkerman R; Oerlemans MMP; Logtenberg MJ; Schols HA; Silva-Lagos LA; López-Velázquez G; de Vos P
    Carbohydr Polym; 2022 Feb; 277():118893. PubMed ID: 34893295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune modulation by different types of β2→1-fructans is toll-like receptor dependent.
    Vogt L; Ramasamy U; Meyer D; Pullens G; Venema K; Faas MM; Schols HA; de Vos P
    PLoS One; 2013; 8(7):e68367. PubMed ID: 23861894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide associated with β-2,6 fructan mediates TLR4-dependent immunomodulatory activity in vitro.
    Young ID; Nepogodiev SA; Black IM; Le Gall G; Wittmann A; Latousakis D; Visnapuu T; Azadi P; Field RA; Juge N; Kawasaki N
    Carbohydr Polym; 2022 Feb; 277():118606. PubMed ID: 34893207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levan (beta-2, 6-fructan), a major fraction of fermented soybean mucilage, displays immunostimulating properties via Toll-like receptor 4 signalling: induction of interleukin-12 production and suppression of T-helper type 2 response and immunoglobulin E production.
    Xu Q; Yajima T; Li W; Saito K; Ohshima Y; Yoshikai Y
    Clin Exp Allergy; 2006 Jan; 36(1):94-101. PubMed ID: 16393271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β(2 → 1)-β(2 → 6) and β(2 → 1) fructans protect from impairment of intestinal tight junction's gene expression and attenuate human dendritic cell responses in a fructan-dependent fashion.
    Fernández-Lainez C; Aan de Stegge M; Silva-Lagos LA; López-Velázquez G; de Vos P
    Carbohydr Polym; 2023 Nov; 320():121259. PubMed ID: 37659831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of a high molecular weight levan by Bacillus paralicheniformis, an industrially and agriculturally important isolate from the buffalo grass rhizosphere.
    Nasir A; Ahmad W; Sattar F; Ashfaq I; Lindemann SR; Chen MH; Van den Ende W; Ӧner ET; Kirtel O; Khaliq S; Ghauri MA; Anwar MA
    Antonie Van Leeuwenhoek; 2022 Sep; 115(9):1101-1112. PubMed ID: 35840814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Immunomodulatory Properties of β-2,6 Fructans: A Comprehensive Review.
    Young ID; Latousakis D; Juge N
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33921025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular weight dependent structure of the exopolysaccharide levan.
    Hundschell CS; Jakob F; Wagemans AM
    Int J Biol Macromol; 2020 Oct; 161():398-405. PubMed ID: 32512087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Levan-Type Exopolysaccharide from
    Cai G; Liu Y; Li X; Lu J
    J Agric Food Chem; 2019 Jul; 67(28):8029-8034. PubMed ID: 31246026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced production and immunomodulatory activity of levan from the acetic acid bacterium, Tanticharoenia sakaeratensis.
    Aramsangtienchai P; Kongmon T; Pechroj S; Srisook K
    Int J Biol Macromol; 2020 Nov; 163():574-581. PubMed ID: 32629048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of bimodal molecular weight levan by a Lactobacillus reuteri isolate from fish gut.
    Ahmad W; Nasir A; Sattar F; Ashfaq I; Chen MH; Hayat A; Rehman MU; Zhao S; Khaliq S; Ghauri MA; Anwar MA
    Folia Microbiol (Praha); 2022 Feb; 67(1):21-31. PubMed ID: 34453701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular structure of low and high molecular weight levans synthesized by levansucrase.
    Tanaka T; Oi S; Yamamoto T
    J Biochem; 1980 Jan; 87(1):297-303. PubMed ID: 6766925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and structural characterization and antioxidant activity of levan from Bacillus megaterium PFY-147.
    Pei F; Ma Y; Chen X; Liu H
    Int J Biol Macromol; 2020 Oct; 161():1181-1188. PubMed ID: 32561282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactive Levan-Type Exopolysaccharide Produced by
    Al-Qaysi SAS; Al-Haideri H; Al-Shimmary SM; Abdulhameed JM; Alajrawy OI; Al-Halbosiy MM; Moussa TAA; Farahat MG
    J Microbiol Biotechnol; 2021 May; 31(5):696-704. PubMed ID: 33820887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of levan from Bacillus subtilis var. natto and apoptotic effect on SH-SY5Y neuroblastoma cells.
    Vieira AM; Zahed F; Crispim AC; de Souza Bento E; França RFO; Pinheiro IO; Pardo LA; Carvalho BM
    Carbohydr Polym; 2021 Dec; 273():118613. PubMed ID: 34561011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the levan produced by Paenibacillus bovis sp. nov BD3526 and its immunological activity.
    Xu X; Gao C; Liu Z; Wu J; Han J; Yan M; Wu Z
    Carbohydr Polym; 2016 Jun; 144():178-86. PubMed ID: 27083807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of Toll-like receptor signalling in spleen and Peyer's patch dendritic cells.
    Davies JM; MacSharry J; Shanahan F
    Immunology; 2010 Nov; 131(3):438-48. PubMed ID: 20545785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial characterization of a levan type exopolysaccharide (EPS) produced by Leuconostoc mesenteroides showing immunostimulatory and antioxidant activities.
    Taylan O; Yilmaz MT; Dertli E
    Int J Biol Macromol; 2019 Sep; 136():436-444. PubMed ID: 31201910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.
    Leibovici J; Kopel S; Siegal A; Gal-Mor O
    Int J Immunopharmacol; 1986; 8(4):391-403. PubMed ID: 3744640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.